Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
RESEARCH TOOLSreports
Holding GLUE?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 13, 2024 | Versant Venture Capital Vi, L.p. >10% Owner | xxxxxxxxxxxxx | $3404761 |
| Jul 09, 2024 | Dunn Edmund Cao | xxxxxxxxxxxxx | $6166 |
| Jun 05, 2024 | Dunn Edmund Cao | xxxxxxxxxxxxx | $4864 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,916,095 | Institution | 8.01% | 29,250,765 | |
| 3,418,333 | Institution | 5.57% | 20,339,081 | |
| 2,462,920 | Institution | 4.01% | 14,654,374 | |
| 2,209,590 | Institution | 3.60% | 13,147,061 | |
| 1,879,120 | Institution | 3.06% | 11,180,764 | |
| 1,472,331 | Institution | 2.40% | 8,760,369 | |
| 1,171,401 | Institution | 1.91% | 6,969,836 | |
| 957,986 | Institution | 1.56% | 5,700,017 | |
| 868,208 | Institution | 1.41% | 5,165,838 | |
| 852,355 | Institution | 1.39% | 5,071,512 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,418,333 | Institution | 5.57% | 20,339,081 | |
| 2,209,590 | Institution | 3.60% | 13,147,061 | |
| 1,879,120 | Institution | 3.06% | 11,180,764 | |
| 957,986 | Institution | 1.56% | 5,700,017 | |
| 868,208 | Institution | 1.41% | 5,165,838 | |
| 852,355 | Institution | 1.39% | 5,071,512 | |
| 632,258 | Institution | 1.03% | 3,761,935 | |
| 533,603 | Institution | 0.87% | 3,174,938 | |
| 419,477 | Institution | 0.68% | 2,495,888 | |
| 389,927 | Institution | 0.64% | 2,320,066 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,350,106 | Institution | 2.20% | 6,102,479 | |
| 785,886 | Institution | 1.28% | 4,676,022 | |
| 851,620 | Institution | 1.39% | 3,849,322 | |
| 299,713 | Institution | 0.49% | 1,783,292 | |
| 205,497 | Institution | 0.33% | 1,216,542 | |
| 119,601 | Institution | 0.19% | 540,597 | |
| 118,482 | Institution | 0.19% | 535,539 | |
| 71,542 | Institution | 0.12% | 425,675 | |
| 55,127 | Institution | 0.09% | 328,006 | |
| 61,096 | Institution | 0.10% | 276,154 |
FAQ
Who Owns Monte Rosa Therapeutics (GLUE)?
Currently, no data Available
What percentage of Monte Rosa Therapeutics (GLUE) stock is held by institutional investors?
Currently, no data Available
What percentage of Monte Rosa Therapeutics (GLUE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Monte Rosa Therapeutics (GLUE)?
Felix Baker owns the most shares of Monte Rosa Therapeutics (GLUE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.